Voltage criteria of left ventricular hypertrophy in sudden and nonsudden coronary artery disease mortality: The Italian section of the Seven Countries Study☆
References (25)
- et al.
The king of hearts: analysis of 23 patients with heart weighing 1,000 grams or more
Am J Cardiol
(1985) Prevalence and natural history of electrocardiographic left ventricular hypertrophy
Am J Med
(1983)- et al.
Heart rate and cardiovascular mortality: The Framingham study
Am Heart J
(1987) - et al.
The electrocardiogram in prediction of sudden death: Framingham study experience
Am Heart J
(1987) - et al.
Age, period, cohort and geographical area effects on the relationship between risk factors and coronary heart disease mortality: 15 years follow-up of the European cohorts of the Seven Countries Study
J Chron Dis
(1986) - et al.
The Seven Countries: 2,289 deaths in 15 years
Prev Med
(1984) - et al.
The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial limb leads
Am Heart J
(1949) - et al.
Left ventricular hypertrophy. A study of the accuracy of current electrocardiographic criteria when compared with autopsy findings
Circulation
(1955) Pitfalls in the electrocardiographic diagnosis of left ventricular hypertrophy. A correlative study of 200 autopsied patients
Circulation
(1959)Coronary heart disease in Seven Countries
Circulation
(1970)
Probability of middle-aged men developing coronary heart disease in five years
Circulation
Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease
Ann Intern Med
Cited by (21)
High R wave as a risk factor for cardivoascular and all-cause mortality. A 45-year follow-up of 13 cohorts of the Seven Countries Study
2022, Journal of ElectrocardiologyCitation Excerpt :On the other hand, if high R waves alone are interpreted as prevalent left ventricular hypertrophy their meaning is uncertain and prognosis weaker than when they are coupled with negative T waves. The literature on population studies dealing with this issue is not particularly rich and frequently is limited to contributions of the last century [1–16]. This is in part because in modern clinical medicine the study of left ventricle anatomy and function is made by echocardiography.
How the Seven Countries Study contributed to the launch and development of cardiovascular epidemiology in Italy. A historical perspective
2020, Nutrition, Metabolism and Cardiovascular DiseasesCitation Excerpt :However, there are many other analyses that could not be reported in detail. The option was taken to present a selection of them in Table 8, with short sentences describing main findings [93–102]. Technology, statistics and research approach of epidemiology has probably influenced other research areas in Italy.
Comparison of total 12-lead QRS voltage in a variety of cardiac conditions and its usefulness in predicting increased cardiac mass
2013, American Journal of CardiologyPrevalence of electrocardiographic abnormalities in a middle-aged, biracial population: coronary artery risk development in young adults study
2010, Journal of ElectrocardiologyCitation Excerpt :Rautaharju23 has also shown that electrocardiographic estimate of LV mass index can identify a substantially larger fraction of persons at increased risk for cardiovascular mortality than conventional electrocardiographic criteria for LV hypertrophy. In addition, analyses by Kannel21 and Lanti24 have shown that cardiovascular events and sudden cardiac death occurred incrementally in relation to LVM. These data suggest that conventional dichotomous ECG-LVH criteria may be inappropriate for prevalence reporting and, as shown in CARDIA, vary significantly across race independent of conventional CV risk factors.
The decrease in QRS amplitude after aortic valve replacement in patients with aortic valve stenosis
2009, Journal of Electrocardiology
- ☆
This study was supported in part by grant HE-04672 of the US Public Health Service, by the University of Minnesota, Minneapolis, Minnesota, and by Grant 2-1985 from Cardioricerca, Rome, Italy.
- 1
Dr. Lanti received a grant-in-aid from Lirca-Synthélabo, Milan, Italy.